Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Endoscopic Retrograde Cholangiopancreatography Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global endoscopic retrograde cholangiopancreatography market size reached US$ 1.38 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.11 Billion by 2027, exhibiting a growth rate (CAGR) of 7.20% during 2022-2027.

Endoscopic retrograde cholangiopancreatography (ERCP) is an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, and pancreas. It combines X-rays and a long, flexible, lightweight endoscope tube that passes through the esophagus, mouth, and stomach. It helps detect blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct. Besides this, it is a less invasive procedure than open surgery and provides more detailed and accurate information about the pancreaticobiliary system. As a result, the demand for endotherapy devices is increasing across the globe to investigate dysphagia, diarrhea, weight loss, heartburn, and stool blood.

Endoscopic Retrograde Cholangiopancreatography Market Trends:

The growing global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett's disease, biliary, liver, Crohn's, inflammatory bowel, and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), represent one of the key factors positively influencing the market. In addition, the increasing occurrence of benign pancreas and liver tumors, especially among the geriatric population, along with the growing occurrence of cancer across the globe, is driving the market. In line with this, the expansion of hospitals and diagnostic centers is increasing the need for imaging techniques propelling the market growth. Furthermore, rising investments by governments and healthcare organizations of various countries in advanced endoscopy devices and improve endoscopy research is strengthening the market growth. Apart from this, the shifting consumer preference toward minimally invasive surgeries for a speedy recovery and minimal pain and rising awareness about ERCP devices like sphincterotomes are offering a favorable market outlook. Moreover, continuous improvements in healthcare infrastructure and a considerable rise in medical tourism are expected to propel market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global endoscopic retrograde cholangiopancreatography market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, procedure and end user.

Breakup by Product:

  • Endoscope
  • Endotherapy Devices
    • Sphincterotomes
    • Lithotripter
    • Stents
    • Others
  • Visualization Systems
  • Energy Devices
  • Others
     

Breakup by Procedure:

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dialtation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilatation
     

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Procedure, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global endoscopic retrograde cholangiopancreatography market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global endoscopic retrograde cholangiopancreatography market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the procedure?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global endoscopic retrograde cholangiopancreatography market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Endoscopic Retrograde Cholangiopancreatography Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Endoscope
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Endotherapy Devices
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Sphincterotomes
           6.2.2.2 Lithotripter
           6.2.2.3 Stents
           6.2.2.4 Others
        6.2.3 Market Forecast
    6.3    Visualization Systems
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Energy Devices
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Procedure
    7.1    Biliary Sphincterotomy
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Biliary Stenting
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Biliary Dilatation
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Pancreatic Sphincterotomy
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Pancreatic Duct Stenting
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Pancreatic Duct Dilatation
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends 
        8.1.2 Market Forecast
    8.2    Ambulatory Surgery Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Boston Scientific Corporation
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    CONMED Corporation
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Cook Group Incorporated
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Fujifilm Holdings Corporation
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Hobbs Medical Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Johnson & Johnson
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Medi-Globe GmbH
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Medtronic plc
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Olympus Corporation
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Shaili Endoscopy
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    Steris Corporation
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
        14.3.12    Telemed Systems Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio

List of Figures

Figure 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Major Drivers and Challenges
Figure 2: Global: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Product (in %), 2021
Figure 5: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Procedure (in %), 2021
Figure 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by End User (in %), 2021
Figure 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Region (in %), 2021
Figure 8: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: North America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: North America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: United States: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: United States: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Canada: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Canada: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: China: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: China: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Japan: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Japan: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: India: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: India: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: South Korea: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: South Korea: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Australia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Australia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Europe: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Germany: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Germany: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: France: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: France: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Italy: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Italy: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Spain: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Spain: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Russia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Russia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Latin America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Latin America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Brazil: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Brazil: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Mexico: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Mexico: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Country (in %), 2021
Figure 84: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Global: Endoscopic Retrograde Cholangiopancreatography Industry: SWOT Analysis
Figure 86: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Value Chain Analysis
Figure 87: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Procedure (in Million US$), 2022-2027
Table 4: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Competitive Structure
Table 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4